MA
RKDA icon

MYDA Advisors’s Arcadia Biosciences RKDA Stock Holding History

MYDA Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,001
Closed -$40K – 197
2022
Q2 		$40K Hold
1,001
– – 0.01% 175
2022
Q1 		$56K Sell
1,001
-1,502
-60% -$71.6K 0.02% 179
2021
Q4 		$104K Buy
2,503
+1,001
+67% +$65.3K 0.03% 213
2021
Q3 		$124K Buy
1,502
+374
+33% +$35.1K 0.03% 228
2021
Q2 		$134K Buy
+1,128
New +$123K 0.03% 251

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MYDA Advisors's RKDA Position: Q3 2022 in Review

MYDA Advisors sold out of Arcadia Biosciences (RKDA) in Q3 2022, closing a stake of 1,001 shares — an estimated $40K sold.

MYDA Advisors first reported a position in RKDA in Q2 2021 and held it in 5 quarters. The position peaked at $134K in Q2 2021. 24 funds tracked by Wall St. Rank hold RKDA as of Q3 2022.

  • MYDA Advisors reported no remaining Arcadia Biosciences position as of Q3 2022 after selling out during the quarter.
  • MYDA Advisors sold 1,001 Arcadia Biosciences shares in Q3 2022, an estimated $40K.
  • MYDA Advisors first reported a position in Arcadia Biosciences in Q2 2021 and held it in 5 quarters.
  • MYDA Advisors's Arcadia Biosciences position peaked at $134K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2022.

Based on MYDA Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.